Andrew T. Chan, MD, MPH (Damon Runyon Clinical Investigator ‘08-‘13) of Harvard Medical School and Massachusetts General Hospital, Boston, and colleagues, reported an analysis of data from two long-term epidemiologic studies showing that regular use of aspirin significantly reduces the overall risk of cancer. Their findings suggest that the use of aspirin may complement, but not replace, the preventive benefits of colonoscopy and other methods of cancer screening. The study was published in JAMA Oncology and featured in The New York Times.